Regime-Adaptive Bayesian Optimization via Dirichlet Process Mixtures of Gaussian Processes
Yan Zhang, Xuefeng Liu, Sipeng Chen, Sascha Ranftl, Chong Liu, Shibo Li
TL;DR
RAMBO addresses the challenge of multi-regime landscapes in Bayesian Optimization by replacing a single stationary GP with a Dirichlet Process Mixture of Gaussian Processes (DPMM-GP). It derives a collapsed Gibbs inference procedure that marginalizes latent functions, and introduces an adaptive concentration parameter schedule to reveal regimes progressively as data accumulates. The acquisition function is a mixture-aware Expected Improvement that decomposes uncertainty into intra-regime variance and inter-regime disagreement, enabling regime-boundary exploration. Empirical results across synthetic benchmarks and three scientific design domains (molecular conformer optimization, drug discovery, and fusion reactor design) show consistent improvements over state-of-the-art baselines in multi-regime objectives, with RAMBO effectively discovering 3–5 regimes in high-dimensional settings.
Abstract
Standard Bayesian Optimization (BO) assumes uniform smoothness across the search space an assumption violated in multi-regime problems such as molecular conformation search through distinct energy basins or drug discovery across heterogeneous molecular scaffolds. A single GP either oversmooths sharp transitions or hallucinates noise in smooth regions, yielding miscalibrated uncertainty. We propose RAMBO, a Dirichlet Process Mixture of Gaussian Processes that automatically discovers latent regimes during optimization, each modeled by an independent GP with locally-optimized hyperparameters. We derive collapsed Gibbs sampling that analytically marginalizes latent functions for efficient inference, and introduce adaptive concentration parameter scheduling for coarse-to-fine regime discovery. Our acquisition functions decompose uncertainty into intra-regime and inter-regime components. Experiments on synthetic benchmarks and real-world applications, including molecular conformer optimization, virtual screening for drug discovery, and fusion reactor design, demonstrate consistent improvements over state-of-the-art baselines on multi-regime objectives.
